Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative and post-hospital whole-course nutrition management in patients with pancreatoduodenectomy - a single-center prospective randomized controlled trial.

International journal of surgery (London, England)·2024
Same author

Blood-Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma.

ACS nano·2024
Same author

Ill-fitting prosthesis is associated with an increased risk of elevated blood pressures.

Journal of oral rehabilitation·2024
Same author

Melatonin improves salivary gland damage and hypofunction in pSS by inhibiting IL-6/STAT3 signaling through its receptor-dependent manner.

Molecular immunology·2024
Same author

ALK upregulates POSTN and WNT signaling to drive neuroblastoma.

Cell reports·2024
Same author

CellVisioner: A Generalizable Cell Virtual Staining Toolbox based on Few-Shot Transfer Learning for Mechanobiological Analysis.

Research (Washington, D.C.)·2024
Same journal

AdaWGAN: Data Augmentation for Few-Shot HD-sEMG Gesture Recognition Using Single-Trial Data.

IEEE journal of biomedical and health informatics·2026
Same journal

NeuroBooster: a domain-informed self-supervised learning paradigm tailored for brain MRI analysis.

IEEE journal of biomedical and health informatics·2026
Same journal

Graph Convolutional Neural Network based Depression Detection using Brain Functional Connectivity Measures.

IEEE journal of biomedical and health informatics·2026
Same journal

Improving Multi-Sensor Non-Invasive Glucose Detection through AI: A Domain Generalization Approach.

IEEE journal of biomedical and health informatics·2026
Same journal

Unmixing the Neck: Accurate Jugular Venous Pulse Detection From Wearable PPG.

IEEE journal of biomedical and health informatics·2026
Same journal

AD-DAE: Alzheimer's Disease Progression Modeling with Unpaired Longitudinal MRI using Diffusion Auto-Encoders.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K

Adaptive Spectral Graph Attention Filtering Network for Alzheimer's Disease Classification Using Multimodal Data.

Zhi Yang, Bo Cheng, Haitao Gan

    IEEE Journal of Biomedical and Health Informatics
    |April 21, 2026
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a new network analysis method for early Alzheimer's Disease (AD) detection. The Adaptive Spectral Graph Attention Filtering Network (ASGAFN) improves brain network classification accuracy for diagnosing AD and related conditions.

    More Related Videos

    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
    08:43

    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

    Published on: August 7, 2017

    7.5K

    Related Experiment Videos

    Last Updated: Apr 23, 2026

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    2.0K
    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
    08:43

    Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

    Published on: August 7, 2017

    7.5K

    Area of Science:

    • Neuroimaging
    • Artificial Intelligence
    • Computational Neuroscience

    Background:

    • Early detection of Alzheimer's Disease (AD) is crucial for effective intervention.
    • Current graph-based methods for brain network analysis often overlook spectral information.
    • Integrating functional and structural brain network data can improve diagnostic accuracy.

    Purpose of the Study:

    • To develop an advanced network analysis model for enhanced Alzheimer's Disease (AD) classification.
    • To leverage spectral-domain information from brain networks for improved diagnostic performance.
    • To introduce the Adaptive Spectral Graph Attention Filtering Network (ASGAFN) for AD detection.

    Main Methods:

    • Constructed structural and functional brain network graphs using diffusion tensor imaging (DTI) and resting-state functional magnetic resonance imaging (rs-fMRI).
    • Employed a frequency-encoding-guided attention mechanism for adaptive spectral filter learning.
    • Incorporated a spectral energy sensing module for graph-specific adaptation and a Multimodal Fusion and Enhancement Layer (MFEL) for signal integration.

    Main Results:

    • ASGAFN achieved high classification accuracies: 96.64% (AD vs. NC), 90.48% (MCI vs. NC), and 91.75% (AD vs. MCI).
    • The model demonstrated strong performance in a three-class classification task (AD vs. MCI vs. NC) with 87.12% accuracy.
    • ASGAFN significantly outperformed existing baseline methods in AD-related classification tasks.

    Conclusions:

    • The proposed ASGAFN effectively models spectral structures in brain networks for improved AD classification.
    • Spectral-domain modeling and multimodal fusion are effective strategies for enhancing diagnostic accuracy in neurodegenerative diseases.
    • The ASGAFN framework offers a promising tool for early and accurate detection of Alzheimer's Disease stages.